Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Etude de l'efficacité et de la tolérance de l'interféron-pégylé Dans Les myélofibroses
Brief Summary:
Patients who carried primary or secondary myelofibrosis from Philadelphia negative MPNs (PMF/SMF) and who are treated or are about to be treated with pegylated-interferon (mostly α2a) are eligible to this prospective study. Biological and clinical parameters will be collected from the beginning of the drug use until last news.
A non-opposition consent form need to be signed before entering this study.